Coronary Artery Risk Development in Young Adults

Study acronym: CARDIA
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications revised (23)
    • Study description shortened, about 3 words
    v7
  2. Primary and study completion dates: Sep 2008 to Jun 30, 2033v6 Show 5 more changesShow less
    • Trial status: Completed to Active, Not Recruiting
    • Enrollment target: 5115
    • Eligibility criteria expanded, about 22 words
    • Study description expanded, about 25 words
    • Study title shortened, about 1 word
  3. Re-verified, no change to tracked fieldsv5
  4. Study description expanded, about 134 wordsv4
  5. Trial status: Active, Not Recruiting to Completed
    • Primary completion date: Sep 2008
    v3
  6. Study description shortened, about 1 wordv2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Heart, Lung, and Blood Institute (NHLBI)
137 trials monitored
See 6 trials at risk
Heart Disease
8,870 trials monitored
See 440 trials at risk
Diabetes
5,141 trials monitored
See 246 trials at risk
Obesity
3,909 trials monitored
See 165 trials at risk
and 1 more disease
To measure changes in coronary heart disease risk factors in cohorts of Black and White males and females 18 to 30 years of age at baseline. Also, to identify lifestyles during this age span which influence these changes in risk factors.
Trial Details
NCT Number NCT00005130
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Cardiovascular Diseases, Coronary Disease, Hypertension, Heart Diseases, Obesity, Diabetes Mellitus
Related terms Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypertension, Obesity
Enrollment 5,115 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov